Daré Bioscience, Inc.DARENASDAQ
Loading
EBITDA Over TimeExpanding
Percentile Rank71
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

Latest
$-15.91M
↑ 34% vs avg
Percentile
P71
Within normal range
Streak
4 yr
Consecutive growthExpanding
Average
$-24.17M
Historical baseline
PeriodValueYoY Change
TTM$-15.91M+32.0%
2024$-23.41M+23.8%
2023$-30.70M+2.1%
2022$-31.36M+19.7%
2021$-39.04M-42.7%
2020$-27.36M-92.0%
2019$-14.25M-21.9%
2018$-11.69M-4.6%
2017$-11.18M+69.6%
2016$-36.81M-